Can a Plant-Based compound stop deadly clots in pancreatic cancer?
Disease control
Recruiting now
This Phase 3 trial tests whether Kinisoquin™, a supplement-like drug made from isoquercetin plus vitamins C and B3, can prevent dangerous blood clots in 480 people with advanced pancreatic cancer. Participants receive either Kinisoquin™ or a placebo alongside their first chemothe…
Phase: PHASE3 • Sponsor: Quercis Pharma AG • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC